High Rates of Harassment Behaviors Observed in Obstetrics and Gynecology
By Elana Gotkine HealthDay Reporter
THURSDAY, May 9, 2024 -- There are high rates of harassment behaviors within the obstetrics and gynecology (OB-GYN) specialty, according to a review published online May 8 in JAMA Network Open.
Ankita Gupta, M.D., M.P.H., from the University of Louisville Health in Kentucky, and colleagues conducted a systematic review of the prevalence of sexual harassment, bullying, abuse, and discrimination among OB-GYN clinicians and trainees and reviewed interventions aimed at reducing harassment. Ten studies, with 5,852 participants, addressed prevalence, and 12 studies, involving 2,906 participants, addressed interventions.
The researchers found that OB-GYN respondents frequently reported prevalence of sexual harassment (range, 27.6 percent of physicians to 70.9 percent of female gynecologic oncologists), workplace discrimination (67.2 percent of female versus 38.5 percent of male gynecologic oncologists), and bullying (52.8 percent of female gynecologic oncologists). OB-GYN trainees often experienced sexual harassment (69.1 percent), including gender harassment, unwanted sexual attention, and sexual coercion. About one-quarter of medical students surveyed (25.1 percent) indicated mistreatment during their OB-GYN rotation. Physicians, other trainees, and operating room staff were perpetrators of harassment (30.1, 13.1, and 7.7 percent, respectively). No significant decrease in the frequency of sexual harassment was seen with any intervention.
"Interventions to decrease harassment had not been adequately studied, but institutionwide, multipronged approaches with support from varying levels of stakeholders appeared to have the highest efficacy for reductions in mistreatment in medical training," the authors write. "Nevertheless, most interventions were not associated with reduced sexual harassment."
Several authors disclosed ties to the biopharmaceutical industry.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted May 2024
Read this next
AI-Assisted Contours Superior to Cognitively Defined Prostate Cancer Contours
WEDNESDAY, July 3, 2024 -- Artificial intelligence (AI)-assisted definition of prostate cancer contours reduces underestimation of the extent of prostate cancer, according to a...
Allergy-Related Psychological Distress Common
TUESDAY, July 2, 2024 -- Psychological distress related to food allergies (FA) is common globally, according to a study published online June 21 in Allergy. Rebecca C...
Mean Cost of Bringing New Drug to U.S. Market Is $879.3 Million
TUESDAY, July 2, 2024 -- The mean cost of developing a new drug for the U.S. market is estimated to be $879.3 million when both drug development failure and capital costs are...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.